3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Transitional Cell
2
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Carcinoma
1
Interventions
Pemetrexed
3
Carboplatin
3
durvalumab
2
Cisplatin
2
tremelimumab
1
repotrectinib
1
pralsetinib
1
osimertinib
1
brigatinib
1
atezolizumab
1
Surgical Procedures, Operative
1
Paclitaxel
1
Mitomycin
1
Gemcitabine
1
Crizotinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma
×
Mitomycin
×
Clear all
NCT02793128
2020-12-22
Olympus
UroGen Pharma Ltd.
Phase 3
Completed
71 enrolled
16 charts
1 FDA